The complex immunogenetic basis of systemic lupus erythematosus

Autoimmunity Reviews

Volumn 7, Issue 5, 2008, Pages 345-351

  Castro, Jesús ^a   Balada, Eva ^a   Ordi Ros, Josep ^a   Vilardell Tarrés, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Autoantibodies; Candidate genes; Genetics; Immunology; SLE; SNP

Indexed keywords

COMPLEMENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; INTERFERON REGULATORY FACTOR 5; MANNOSE BINDING LECTIN;

APOPTOSIS; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS, CD; COMPLEMENT SYSTEM PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGENETICS; INTERFERON REGULATORY FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAJOR HISTOCOMPATIBILITY COMPLEX; MANNOSE-BINDING LECTIN; RECEPTORS, FC;

EID: 43449084631     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.01.001     Document Type: Review

References (37)

1. Rus V.H.A., and Hochberg M.C. Systemic lupus erythematosus. In: Silma A. (Ed). Epidemiology of the rheumatic diseases, Edn 2 (2001), Oxford University Press 123-140
2. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349 (2003) 1526-1533
3. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
4. Graham R.R., Ortmann W.A., Langefeld C.D., Jawaheer D., Selby S.A., Rodine P.R., et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 71 (2002) 543-553
5. Ghebrehiwet B., and Peerschke E.I. Role of C1q and C1q receptors in the pathogenesis of systemic lupus erythematosus. Curr Dir Autoimmun 7 (2004) 87-97
6. Manderson A.P., Botto M., and Walport M.J. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22 (2004) 431-456
7. Karassa F.B., Trikalinos T.A., and Ioannidis J.P. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 46 (2002) 1563-1571
8. Zuniga R., Ng S., Peterson M.G., Reveille J.D., Baethge B.A., Alarcon G.S., et al. Low-binding alleles of Fcgamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients. Arthritis Rheum 44 (2001) 361-367
9. Kyogoku C., Tsuchiya N., Matsuta K., and Tokunaga K. Studies on the association of Fc gamma receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: evidence for a genetic interaction between HLA-DRB1 and FCGR3A. Genes Immun 3 (2002) 488-493
10. Gonzalez-Escribano M.F., Aguilar F., Sanchez-Roman J., and Nunez-Roldan A. FcgammaRIIA, FcgammaRIIIA and FcgammaRIIIB polymorphisms in Spanish patients with systemic lupus erythematosus. Eur J Immunogenet 29 (2002) 301-306
11. Manger K., Repp R., Jansen M., Geisselbrecht M., Wassmuth R., Westerdaal N.A., et al. Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms. Ann Rheum Dis 61 (2002) 786-792
12. Siriboonrit U., Tsuchiya N., Sirikong M., Kyogoku C., Bejrachandra S., Suthipinittharm P., et al. Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 61 (2003) 374-383
13. Lee E.B., Lee Y.J., Baek H.J., Kang S.W., Chung E.S., Shin C.H., et al. Fcgamma receptor IIIA polymorphism in Korean patients with systemic lupus erythematosus. Rheumatol Int 21 (2002) 222-226
14. Salmon J.E., Millard S., Schachter L.A., Arnett F.C., Ginzler E.M., Gourley M.F., et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 97 (1996) 1348-1354
15. Magnusson V., Johanneson B., Lima G., Odeberg J., Alarcon-Segovia D., and Alarcon-Riquelme M.E. Both risk alleles for FcgammaRIIA and FcgammaRIIIA are susceptibility factors for SLE: a unifying hypothesis. Genes Immun 5 (2004) 130-137
16. Chu Z.T., Tsuchiya N., Kyogoku C., Ohashi J., Qian Y.P., Xu S.B., et al. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 63 (2004) 21-27
17. Su K., Li X., Edberg J.C., Wu J., Ferguson P., and Kimberly R.P. A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J Immunol 172 (2004) 7192-7199
18. Garred P., Larsen F., Madsen H.O., and Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 40 (2003) 73-84
19. Takahashi R., Tsutsumi A., Ohtani K., Goto D., Matsumoto I., Ito S., et al. Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus. Clin Exp Immunol 136 (2004) 585-590
20. Huang Y.F., Wang W., Han J.Y., Wu X.W., Zhang S.T., Liu C.J., et al. Increased frequency of the mannose-binding lectin LX haplotype in Chinese systemic lupus erythematosus patients. Eur J Immunogenet 30 (2003) 121-124
21. Villarreal J., Crosdale D., Ollier W., Hajeer A., Thomson W., Ordi J., et al. Mannose binding lectin and FcgammaRIIa (CD32) polymorphism in Spanish systemic lupus erythematosus patients. Rheumatology (Oxford) 40 (2001) 1009-1012
22. Hudson L.L., Rocca K., Song Y.W., and Pandey J.P. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 111 (2002) 452-455
23. Fernandez-Blanco L., Perez-Pampin E., Gomez-Reino J.J., and Gonzalez A. A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum 50 (2004) 328-329
24. Liu M.F., Wang C.R., Lin L.C., and Wu C.R. CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus 10 (2001) 647-649
25. Prokunina L., Castillejo-Lopez C., Oberg F., Gunnarsson I., Berg L., Magnusson V., et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32 (2002) 666-669
26. Prokunina L., Gunnarsson I., Sturfelt G., Truedsson L., Seligman V.A., Olson J.L., et al. The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum 50 (2004) 327-328
27. Ferreiros-Vidal I., Gomez-Reino J.J., Barros F., Carracedo A., Carreira P., Gonzalez-Escribano F., et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 50 (2004) 2590-2597
28. Ronnblom L., Eloranta M.L., and Alm G.V. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 54 (2006) 408-420
29. Sigurdsson S., Nordmark G., Goring H.H., Lindroos K., Wiman A.C., Sturfelt G., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76 (2005) 528-537
30. Graham R.R., Kozyrev S.V., Baechler E.C., Reddy M.V., Plenge R.M., Bauer J.W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38 (2006) 550-555
31. Morley M., Molony C.M., Weber T.M., Devlin J.L., Ewens K.G., Spielman R.S., et al. Genetic analysis of genome-wide variation in human gene expression. Nature 430 (2004) 743-747
32. Kozyrev S.V., Lewen S., Reddy P.M., Pons-Estel B., Witte T., Junker P., et al. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 56 (2007) 1234-1241
33. Ferreiro-Neira I., Calaza M., Alonso-Perez E., Marchini M., Scorza R., Sebastiani G.D., et al. Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes Immun 8 (2007) 429-438
34. Kelly J.A., Moser K.L., and Harley J.B. The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun 3 Suppl 1 (2002) S71-S85
35. Tsao B.P. The genetics of human systemic lupus erythematosus. Trends Immunol 24 (2003) 595-602
36. Balada E., Ordi-Ros J., and Vilardell-Tarres M. DNA methylation and systemic lupus erythematosus. Ann N Y Acad Sci 1108 (2007) 127-136
37. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100 (2003) 2610-2615